The global gastro esophageal reflux disease (GERD) drug market is anticipated to grow at a CAGR of 2.3% during the forecast period. The major factor for the growth of the market is the increasing disorders which are caused by GERD, as well as change in lifestyle and unhealthy eating habits, which will fuel the growth of the market during the forecast period.

There has been increasing incidences of acidic taste in the mouth, heartburn, dry cough, asthma, and many others, which will fuel the growth of the market during the forecast period. The most commonly used drugs include NSAIDs, biphospohonates, and potassium tablets for the treatment of the gastro esophageal reflux disease. Antacids are the most used drug type for the treatment of the GERD, antacids help in reducing stomach ache, heartburn, acid indigestion, and many others.  Antacid works directly by counteracting the acidity inside the stomach by providing quick-relief to the patient. In 2019, antacid held the market share of 49.9% across the globe to treat disorders caused by GERD. Some of the antacids are Aluminium hydroxide gel, Calcium carbonate, Magnesium hydroxide, Gelusil, Mylanta, Pepto-Bismol, and many others. In October 2020, Dr. Reddy’s Laboratories launched a generic product in the US to treat GERD disorder like the acid reflux; the tablets are called as famotidine, which  areeffective against heartburn, acid indigestion, sour stomach, and many others. Some of the key global players in the thermal gap fillers market include Johnson and Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer, Inc., Novartis AG, Eisai Co. Ltd., and many others.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By  Drug Type

o By Application

• Competitive Landscape -Johnson and Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer, Inc., Novartis AG, Eisai Co. Ltd.,  and many others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global gastro esophageal reflux disease (GERD) drug market

o By Type

• Tablet
• Chewable 
• Injectable

o By Application 

• Hospital
• Laboratory
• Others

Regions Covered